Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Jul 14, 2023.

Shortage details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0480-3565-01
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)
Initial Posting
Jul 14, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.